Haemonetics (HAE) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Barrington Research Downgrades Haemonetics (HAE) to Market Perform
August 3, 2016 8:02 AM EDTBarrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform and removed its price target (prior $32.00).
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $34.50 yesterday.
... MoreHaemonetics (HAE) PT Raised to $40 at Jefferies
August 2, 2016 7:20 AM EDTJefferies analyst Anthony Petrone reiterated a Buy rating and raised his price target on Haemonetics (NYSE: HAE) to $40.00 (from $32.00) following mixed Q1 with $3mn top-line beat offset by a $0.03 EPS miss,
commented, "Underlying growth trends in Plasma and TEG were as expected and... More
